找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

12345
返回列表
打印 上一主題 下一主題

Titlebook: Disease-modifying Therapy in Vasculitides; Cees G. M. Kallenberg,Jan W. Cohen Tervaert Book 2001 Birkh?user Verlag 2001 Internal medicine.

[復(fù)制鏈接]
樓主: hexagon
41#
發(fā)表于 2025-3-28 16:53:36 | 只看該作者
42#
發(fā)表于 2025-3-28 20:46:03 | 只看該作者
T-cell directed treatment: anti-thymocyte globulin, with a cumulative dose higher than 100 g [.]. There is a definite need to replace cyclophosphamide in these refractory cases. In other patients, standard treatment has to be avoided because severe side-effects already developed. Few patients have been reported to have responded to Cyclosporin A [.]
43#
發(fā)表于 2025-3-29 02:19:55 | 只看該作者
44#
發(fā)表于 2025-3-29 06:22:08 | 只看該作者
45#
發(fā)表于 2025-3-29 09:39:29 | 只看該作者
Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-verapy after a remission is induced with cyclophosphamide and steroids [.]. Azathioprine is considered less effective in inducing remission than cyclophosphamide, but its long-term toxicity is much lower [., .]. The potential of azathioprine as maintenance therapy was recently investigated and compar
46#
發(fā)表于 2025-3-29 12:29:18 | 只看該作者
10樓
47#
發(fā)表于 2025-3-29 18:14:30 | 只看該作者
10樓
48#
發(fā)表于 2025-3-29 20:00:35 | 只看該作者
10樓
12345
返回列表
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 07:39
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
顺平县| 灌阳县| 古田县| 勐海县| 新民市| 合川市| 台州市| 阜康市| 新泰市| 朝阳区| 甘孜县| 兴安盟| 石渠县| 四子王旗| 太白县| 绥中县| 蕲春县| 广河县| 龙江县| 英德市| 弥渡县| 论坛| 桦南县| 普安县| 伊宁县| 中宁县| 昆山市| 资兴市| 荣昌县| 崇左市| 华蓥市| 定边县| 拉孜县| 尼木县| 峨眉山市| 马尔康县| 云阳县| 威远县| 监利县| 雷州市| 南昌市|